About Harmony Biosciences Holdings Inc
- Industry: Pharmaceuticals
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.harmonybiosciences.com/
Frequently Asked Questions
What is the 52-week range for HRMY?
The 52-week high is $43.49 and the 52-week low is $25.52.
What is the P/E ratio for HRMY?
The Price to Earnings (P/E) ratio is 12.73.
What is the dividend yield for HRMY?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is 20.06%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is 18.88%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 2.48.
Analyst Recommendation Trends
Wall Street analyst consensus for HRMY over the last few months:
Latest HRMY News
Harmony Biosciences Announces Poster Presentation at the 17th European Narcolepsy Days
PLYMOUTH MEETING, Pa., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will present a poster featuring information from its ongoing Phase 3 trials of HBS-301, including ONSTRIDE-1 in narcolepsy and ONSTRIDE-2 in idiopathic hypersomnia. This poster will be presented at the 17th European Narcolepsy Days, taking place October 2–3, 2026, in Bern, Switzerland. Poster details are listed below: Abstract Title:Phase 3, randomized, double-blind,
Engaging In Options Activity, Kumar Budur Exercises Options Valued At $262K In Harmony Biosciences Hldgs
On September 9, it was revealed in an SEC filing that Kumar Budur, Chief Medical Officer at Harmony Biosciences Hldgs (NASDAQ:HRMY) executed a significant exercise of company stock options. What Happened: Budur, Chief
Editas (EDIT) Up 6.2% Since Last Earnings Report: Can It Continue?
Editas (EDIT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is Harmony Biosciences (HRMY) Up 12.1% Since Last Earnings Report?
Harmony Biosciences (HRMY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Harmony Biosciences Announces Poster Presentations at the 16th European Epilepsy Congress
PLYMOUTH MEETING, Pa., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will present encore data from the company’s investigation of EPX-100 (clemizole hydrochloride) at the 16th European Epilepsy Congress being held from September 5-9, in Athens, Greece. The company is investigating EPX-100 for the treatment of Dravet syndrome and Lennox-Gastaut syndrome in the ongoing ARGUS and LIGHTHOUSE trials, respectively. These trials are current
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-18 | Budur Kumar | -25,446 | - | - |
| 2026-09-18 | Budur Kumar | -10,406 | - | - |
| 2026-09-18 | Budur Kumar | -35,852 | $43.0545 | $1,543,590 |
| 2026-09-18 | Budur Kumar | +25,446 | $30.27 | $770,250 |
| 2026-09-18 | Budur Kumar | +10,406 | $30.69 | $319,360 |
| 2026-09-17 | Budur Kumar | -400 | - | - |
| 2026-09-17 | Budur Kumar | -400 | - | - |
| 2026-09-17 | Budur Kumar | -800 | $43 | $34,400 |
| 2026-09-17 | Budur Kumar | +400 | $30.27 | $12,108 |
| 2026-09-17 | Budur Kumar | +400 | $30.69 | $12,276 |
| 2026-09-16 | Budur Kumar | -900 | - | - |
| 2026-09-16 | Budur Kumar | -900 | - | - |
| 2026-09-16 | Budur Kumar | -1,800 | $43.0146 | $77,426 |
| 2026-09-16 | Budur Kumar | +900 | $30.27 | $27,243 |
| 2026-09-16 | Budur Kumar | +900 | $30.69 | $27,621 |
| 2026-09-08 | Budur Kumar | -10,754 | - | - |
| 2026-09-08 | Budur Kumar | -12,200 | - | - |
| 2026-09-08 | Budur Kumar | -22,954 | $43.1014 | $989,350 |
| 2026-09-08 | Budur Kumar | +10,754 | $30.27 | $325,524 |
| 2026-09-08 | Budur Kumar | +12,200 | $30.69 | $374,418 |
| 2026-09-08 | Budur Kumar | -1,000 | $42.7947 | $42,795 |
| 2026-09-08 | Budur Kumar | -4,500 | $42.2475 | $190,114 |
| 2026-09-04 | Budur Kumar | -5,500 | $41.9839 | $230,911 |
| 2026-05-14 | Philip Ron M | +21,872 | - | - |
| 2026-05-14 | Sabater Juan A. | +21,872 | - | - |
| 2026-05-14 | Szyper Linda M | +21,872 | - | - |
| 2026-05-14 | Sender Gary | +21,872 | - | - |
| 2026-05-14 | Graf R. Mark | +21,872 | - | - |
| 2026-05-14 | Germano Geno J | +21,231 | - | - |
| 2026-05-01 | Budur Kumar | -18,750 | - | - |
| 2026-05-01 | Budur Kumar | -8,882 | $31.83 | $282,714 |
| 2026-05-01 | Budur Kumar | +18,750 | - | - |
| 2026-04-14 | Reicin Glenn | +164,309 | - | - |
| 2026-04-07 | Zaeske Adam H. | -7,500 | - | - |
| 2026-04-07 | Zaeske Adam H. | -3,173 | $27.62 | $87,638 |
| 2026-04-07 | Zaeske Adam H. | +7,500 | - | - |
| 2026-04-02 | Anastasiou Peter | +212,241 | - | - |
| 2026-04-02 | Ignelzi Troy A. | +17,710 | - | - |
| 2026-01-26 | Kapadia Sandip | -3,746 | $37.152 | $139,171 |
| 2026-01-25 | Budur Kumar | -2,662 | - | - |
| 2026-01-25 | Budur Kumar | -1,372 | $36.82 | $50,517 |
| 2026-01-25 | Budur Kumar | +2,662 | - | - |
| 2026-01-25 | Serafin Andrew | -2,600 | - | - |
| 2026-01-25 | Serafin Andrew | -1,126 | $36.82 | $41,459 |
| 2026-01-25 | Serafin Andrew | +2,600 | - | - |
| 2026-01-25 | Kapadia Sandip | -4,725 | - | - |
| 2026-01-25 | Kapadia Sandip | -2,553 | $36.82 | $94,001 |
| 2026-01-25 | Kapadia Sandip | +4,725 | - | - |
| 2026-01-25 | Dayno Jeffrey M. | -13,000 | - | - |
| 2026-01-25 | Dayno Jeffrey M. | -5,654 | $36.82 | $208,180 |
| 2026-01-25 | Dayno Jeffrey M. | +13,000 | - | - |
| 2026-01-24 | Budur Kumar | -2,188 | - | - |
| 2026-01-24 | Budur Kumar | -1,153 | $36.82 | $42,453 |
| 2026-01-24 | Budur Kumar | +2,188 | - | - |
| 2026-01-24 | Serafin Andrew | -2,500 | - | - |
| 2026-01-24 | Serafin Andrew | -1,116 | $36.82 | $41,091 |
| 2026-01-24 | Serafin Andrew | +2,500 | - | - |
| 2026-01-24 | Kapadia Sandip | -3,813 | - | - |
| 2026-01-24 | Kapadia Sandip | -2,239 | $36.82 | $82,440 |
| 2026-01-24 | Kapadia Sandip | +3,813 | - | - |
| 2026-01-24 | Dayno Jeffrey M. | -10,500 | - | - |
| 2026-01-24 | Dayno Jeffrey M. | -4,785 | $36.82 | $176,184 |
| 2026-01-24 | Dayno Jeffrey M. | +10,500 | - | - |
| 2026-01-22 | Zaeske Adam H. | +16,200 | - | - |
| 2026-01-22 | Zaeske Adam H. | +56,900 | - | - |
| 2026-01-22 | Budur Kumar | +12,200 | - | - |
| 2026-01-22 | Budur Kumar | +42,600 | - | - |
| 2026-01-22 | Serafin Andrew | +12,200 | - | - |
| 2026-01-22 | Serafin Andrew | +42,600 | - | - |
| 2026-01-22 | Kapadia Sandip | +12,200 | - | - |
| 2026-01-22 | Kapadia Sandip | +42,600 | - | - |
| 2026-01-22 | Dayno Jeffrey M. | +52,900 | - | - |
| 2026-01-22 | Dayno Jeffrey M. | +184,600 | - | - |
| 2026-01-15 | Kapadia Sandip | -20,961 | $35.9159 | $752,833 |
| 2025-12-12 | Dayno Jeffrey M. | -20,000 | - | - |
| 2025-12-12 | Dayno Jeffrey M. | -5,933 | $40.1073 | $237,957 |
| 2025-12-12 | Dayno Jeffrey M. | -20,000 | $40.1073 | $802,146 |
| 2025-12-12 | Dayno Jeffrey M. | +20,000 | $8.22 | $164,400 |
| 2025-12-05 | Kapadia Sandip | -20,000 | - | - |
| 2025-12-05 | Kapadia Sandip | -20,000 | $39.5448 | $790,896 |
| 2025-12-05 | Kapadia Sandip | +20,000 | $29.03 | $580,600 |
| 2025-11-21 | Kapadia Sandip | -3,427 | $35 | $119,945 |